Nessan Bermingham is the entrepreneur and Life Sciences investor whose vision and drive made Intellia “one of the top 10 biotech start-ups in 2014” according to Nature Biotechnology and recently one of FierceBiotech's "Fierce 15".
Nessan has more than 15 years of experience in Life Sciences investments, including small molecules, biologics, medical devices, and diagnostics through venture, public, and secondary markets. As a partner at Atlas Venture and Omega Funds, and founding partner of Bio Equity Capital, he successfully managed multiple investments across the United States and Europe. In his career, Nessan co-founded a number of healthcare and biotech startup companies. Most recently Nessan was a venture partner at Atlas Venture and was previously the CEO of Tal Medical, a medical device company spun out of Harvard Medical School. Nessan has established a vast transatlantic network of experts, management leaders, investors and companies that Intellia can leverage as it continues to grow.